Medication info
Cazatan Tablets (Losartan Potassium)

Cazatan Tablets (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
(Domestic) 30 tablets/bottle, 300 tablets/bottle (Export) 30 tablets (10 tablets/PTP x 3), 100 tablets (10 tablets/PTP x 10)
Approval status
Active

MFDS item code 200501288 · Notified 2005.02.16 · Insurance code 650301340

Summary

Main use
Treatment of hypertension and diabetic nephropathy associated with hypertension in type 2 diabetes
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended to take it at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses per day or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is necessary in older adults 75 years of age or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 50mg once daily. Children and adolescents 6 years of age and older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and diabetic nephropathy associated with hypertension in type 2 diabetes

  • Hypertension
  • nephropathy in patients with type 2 diabetes
View approved original text

This medicine is used to treat hypertension. It is particularly effective for treating kidney disease in patients with type 2 diabetes who have hypertension. It helps control hypertension and prevent related kidney damage.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended to take it at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses per day or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is necessary in older adults 75 years of age or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 50mg once daily. Children and adolescents 6 years of age and older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters; therefore, women who are pregnant or may become pregnant should not take it. Discontinue immediately if pregnancy is confirmed, and regularly check the fetal condition with ultrasound or other means. This medication should not be administered to patients with severely impaired liver function or certain genetic lactose intolerance. Additionally, those with a history of angioedema or specific kidney diseases should avoid taking it. Elderly patients, those with poor kidney function, and patients with high serum potassium levels should use this medication cautiously, as excessively low blood pressure may lead to issues with the heart or cerebral blood vessels, requiring careful attention. Generally, this medication is well tolerated, but side effects such as dizziness, muscle cramps, cough, and dyspepsia may occur. Rarely, serious side effects like angioedema, liver function abnormalities, renal failure, and hypoglycemia may arise, necessitating immediate consultation with medical personnel if unusual symptoms occur. Regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary while taking this medication to detect any abnormalities. Particularly, caution is required to avoid taking potassium supplements or potassium-containing salt substitutes, as there is a risk of hyperkalemia. Interactions with other antihypertensives, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), lithium, and others may occur, so it is essential to inform healthcare providers about any other medications being taken. This medication is not recommended for breastfeeding women. If it must be taken, breastfeeding should be discontinued. It is not used in children, especially those under 6 years or those with severely impaired kidney function, as its safety and efficacy have not been established. In cases of overdose, symptoms such as hypotension and bradycardia may occur, requiring immediate treatment, so caution is advised. Keep this medication out of reach of children and do not transfer it to other containers for safety. During treatment, be cautious while driving or operating machinery due to potential dizziness.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 132 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm scaling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree AV block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • myotonia
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decrease
  • reduced libido
  • memory impairment
  • migraine
  • neuralgia
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnolence
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flush
  • photosensitivity
  • pruritus
  • rash
  • sweating
  • hives
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • polyuria
  • urethral infection
  • dry cough
  • lip swelling
  • angioedema
  • vasculitis
  • anaphylactic syndrome
  • liver function abnormalities
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • creatine kinase elevation
  • rhabdomyolysis
  • dysgeusia
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • ALT elevation
  • serum creatinine increase
  • hemoglobin and hematocrit decrease
  • liver enzyme elevation
  • serum bilirubin increase
  • hypoglycemia
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is recommended to maintain storage temperatures between 1 degree to 30 degrees Celsius at room temperature. This way, the efficacy of the medication can be well preserved.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

(Domestic) 30 tablets/bottle, 300 tablets/bottle (Export) 30 tablets (10 tablets/PTP x 3), 100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.